Mozzarc maybe you should go and work at PAR and help PR with the journey. We all understand that Bio's are a difficult beast but to date PR's communications strategy has been nothing short of a cluster FXXk. As you know I have been here with you for a long time and its the science that keeps me here (which makes sense as it is a Bio stock) but specifically the size of the market, the fact it is approved for veterinary, no AE's etc etc.
It would be just nice if he delivered on one thing when he said he was going to rather than continually kicking the can down the road as thats what it feels like. Just like dungiven I listen to PR at AGM's etc and he inspires confidence then we seem to go back down the rabbit hole. We are almost 6 months since ethics approval and the clock is ticking.. Still crickets, meanwhile we have people getting the drug from compounding because it works. How ridiculous is that..
Thank-you for spending the time to once again show us how good the science is...
The Pool
PAR Price at posting:
29.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)